Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$807M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$497M |
| 3 |
RNAM
Avidity Biosciences
RNAM
|
+$390M |
| 4 |
Kenvue
KVUE
|
+$379M |
| 5 |
Broadcom
AVGO
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$409M |
| 2 |
Visa
V
|
+$354M |
| 3 |
Advanced Micro Devices
AMD
|
+$328M |
| 4 |
Meta Platforms (Facebook)
META
|
+$317M |
| 5 |
Lockheed Martin
LMT
|
+$316M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.61% |
| 2 | Consumer Discretionary | 9.64% |
| 3 | Healthcare | 8.17% |
| 4 | Industrials | 8.1% |
| 5 | Financials | 8.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
CALL
Vertiv
VRT
$98.5B
| $2.64M | ﹤0.01% |
16,300
-3,800
| -19% | -$660K |
|
1677
AT&T
T
$177B
| $2.64M | ﹤0.01% |
106,095
-213,149
| -67% | -$5.4M |
|
1678
Corning
GLW
$127B
| $2.63M | ﹤0.01% |
30,050
-82,534
| -73% | -$7.11M |
|
1679
CALL
Sea Limited
SE
$75.4B
| $2.63M | ﹤0.01% |
20,600
-38,600
| -65% | -$5.72M |
|
1680
CALL
Cadence Design Systems
CDNS
$91.4B
| $2.63M | ﹤0.01% |
8,400
-5,000
| -37% | -$1.63M |
|
1681
CALL
Direxion Daily FTSE China Bull 3X ETF
YINN
$676M
| $2.62M | ﹤0.01% |
61,400
+22,000
| +56% | +$1.04M |
|
1682
Prologis
PLD
$136B
| $2.61M | ﹤0.01% |
20,447
-464,700
| -96% | -$57.9M |
|
1683
CALL
Philip Morris
PM
$302B
| $2.6M | ﹤0.01% |
16,200
+5,500
| +51% | +$852K |
|
1684
CALL
Hims & Hers Health
HIMS
$7.41B
| $2.6M | ﹤0.01% |
80,000
-13,400
| -14% | -$574K |
|
1685
Intapp
INTA
$3.11B
| $2.59M | ﹤0.01% |
+56,582
| New | +$2.35M |
|
1686
CALL
NIO
NIO
$11.2B
| $2.59M | ﹤0.01% |
508,200
+15,800
| +3% | +$97.5K |
|
|
BBNX
1687
Beta Bionics
BBNX
$870M
| $2.59M | ﹤0.01% |
84,973
+82,458
| +3,279% | +$2.2M |
|
1688
Novavax
NVAX
$1.56B
| $2.59M | ﹤0.01% |
384,991
+26,864
| +8% | +$203K |
|
1689
Truist Financial
TFC
$61.4B
| $2.58M | ﹤0.01% |
52,499
-2,830,533
| -98% | -$130M |
|
1690
Ball Corp
BALL
$17B
| $2.57M | ﹤0.01% |
+48,545
| New | +$2.39M |
|
1691
CALL
Marathon Digital Holdings
MARA
$4.57B
| $2.56M | ﹤0.01% |
285,500
-105,500
| -27% | -$1.56M |
|
1692
Progress Software
PRGS
$1.78B
| $2.55M | ﹤0.01% |
+59,361
| New | +$2.59M |
|
1693
Pebblebrook Hotel Trust
PEB
$2.07B
| $2.54M | ﹤0.01% |
223,959
-155,536
| -41% | -$1.71M |
|
|
FITB
1694
Fifth Third Bancorp
FITB
$49.8B
| $2.53M | ﹤0.01% |
54,126
-5,705
| -10% | -$251K |
|
|
EXAS
1695
CALL
DELISTED
Exact Sciences
EXAS
| $2.53M | ﹤0.01% |
24,900
+17,100
| +219% | +$1.37M |
|
1696
CALL
ServiceNow
NOW
$131B
| $2.51M | ﹤0.01% |
16,400
+13,400
| +447% | +$2.3M |
|
|
TE
1697
T1 Energy
TE
$1.37B
| $2.51M | ﹤0.01% |
+375,692
| New | +$1.66M |
|
|
CTRA
1698
DELISTED
Coterra Energy
CTRA
| $2.49M | ﹤0.01% |
94,583
+59,700
| +171% | +$1.5M |
|
1699
ICICI Bank
IBN
$109B
| $2.48M | ﹤0.01% |
+83,364
| New | +$2.56M |
|
1700
WSFS Financial
WSFS
$4.01B
| $2.48M | ﹤0.01% |
44,948
+37,708
| +521% | +$2.06M |
|
Similar funds
Dmitry Balyasny's Q4 2025 Portfolio in Review
As of Q4 2025, Dmitry Balyasny held 3,669 positions worth $78.8B, down 0.17% from $78.9B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Dmitry Balyasny withdrew a net $4.13B in Q4 2025, closing 643 positions and reducing 1,102 holdings. Its most notable exit was Mr. Cooper, an estimated $277M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Dmitry Balyasny opened a new position in Avidity Biosciences worth $436M.
- Dmitry Balyasny's largest Q4 2025 buy was Avidity Biosciences: 6,040,590 shares worth $436M.
- Dmitry Balyasny added most to Amazon in Q4 2025, an estimated $807M increase.
- Dmitry Balyasny's biggest Q4 2025 reduction was Apple, cutting an estimated $409M.
- Dmitry Balyasny fully exited Mr. Cooper in Q4 2025, selling an estimated $277M.
- Dmitry Balyasny's ten largest holdings make up 15% of its $78.8B portfolio in Q4 2025.
- Dmitry Balyasny opened 809 new positions and closed 643 in Q4 2025.
- Dmitry Balyasny's portfolio value fell 0.17% quarter-over-quarter to $78.8B.
Based on Balyasny Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.